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Introduction: Synovial inflammation and joint destruction in rheumatoid arthritis (RA) may progress despite clinical
remission. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is increasingly used to detect
synovial inflammation in RA. Although small joints such as metacarpophalangeal (MCP) joints are mainly affected by
RA, MRI findings have never been directly compared to histological synovitis in MCP synovial tissue. The objective
of the current study was therefore to analyse if DCE-MRI relates to histological signs of synovitis small RA joints.
Methods: In 9 RA patients, DCE-MRI (3 Tesla, dynamic 2D T1 weighted turbo-flash sequence) of the hand was
performed prior to arthroscopically-guided synovial biopsies from the second MCP of the imaged hand. Maximum
enhancement (ME), rate of early enhancement, and maximum rate of enhancement were assessed in the MCP.
Synovial biopsies were stained for determination of sublining CD68 and the Synovitis Score. Correlations between
MRI and histological data were calculated according to Spearman.
Results: ME of the MCP significantly correlated to sublining CD68 staining (r = 0.750, P = 0.02), the Synovitis
Score (r = 0.743, P = 0.02), and the subscores for lining layer hypertrophy (r = 0.789, P = 0.01) and cellular density
(r = 0.842; P = 0.004).
Conclusions: Perfusion imaging of synovial tissue in RA finger joints employing DCE-MRI reflects histological
synovial inflammation. According to our study, ME is the most closely associated parameter amongst the measures
considered.Introduction
Rheumatoid arthritis (RA) is a debilitating disease cha-
racterized by chronic inflammation and proliferation of
synovial tissue with subsequent destruction of cartilage
and bone [1]. The target of modern therapeutic strate-
gies consists of complete remission, which is commonly
identified based on clinical grounds in conjunction with
inflammatory markers such as C-reactive protein [2].
However, joint destruction may progress in patients thus
considered to be in remission [3,4]. Hence, additional* Correspondence: stefan.vordenbaeumen@med.uni-duesseldorf.de
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article, unless otherwise stated.tools are needed to directly assess synovitis and cartilage
destruction. Magnetic resonance imaging (MRI) is in-
creasingly used for this purpose [5]. In particular, syno-
vitis in MRI has been shown to relate to the histological
degree of synovial inflammation in human RA [6,7] and
arthritis models [8,9]. Generally, most correlative studies
on MRI and synovial histology in RA were performed on
large joints, especially knee joints [6,7], due to more eas-
ily accessible synovial tissue [10,11]. These findings are
commonly extrapolated when MRI findings of small
joints are assessed that are predominantly involved in
RA, particularly in early disease states [12]. Data vali-
dating MRI findings by synovial histology of metacarpo-
phalangeal (MCP) joints are so far scarce: gadoliniumCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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croscopic findings of hyperemia and vascularity, but
synovial biopsies were not systematically assessed [13].
Data on dynamic MRI of MCP joints and corresponding
histological findings are lacking. In the current study, we
performed contrast-enhanced dynamic MRI of the hand
with determination of perfusion parameters of synovial
tissue of the MCP2 joint prior to arthroscopically guided
synovial sampling of the same joint with histological
analysis of synovial inflammation, with the aim to cor-
relate dynamic MRI to histological synovitis.
Methods
Patients and synovial sampling
Nine patients with RA based on 2010 American College of
Rheumatology/European League Against Rheumatism cri-
teria with a 28-joint disease activity score (DAS28) >3.2,
who required initiation of disease-modifying antirheumatic
drug therapy (three patients, methotrexate) or a switch
of medication (patients with methotrexate additionally
received adalimumab (four patients), tocilizumab (one
patient), or rituximab (one patient)) and gave their full
informed written consent, were recruited into the study.
After clinical examination (including DAS28, patient-
reported ratings on 10-point scales for pain of the domin-
ant MCP2 joint and global well-being, physician-rated 68-
tender and swollen joint count), all patients received MRI
of the more severely affected hand up to 1 week prior to
arthroscopy-guided synovial sampling as described previ-
ously [10]. A total of six synovial biopsies were obtained
from each patient under visual control from macroscopic-
ally inflamed areas and were snap frozen in Tissue-Tek
(Sakura Finetek Germany, Staufen, Germany). The study
was conducted according to the principles expressed in
the Declaration of Helsinki and was approved by the eth-
ics committee of the Medical Faculty of Heinrich-Heine-
University (study number 3390).
Histological assessment of synovitis
The work-up and scoring of tissue sections was carried
out in a blinded fashion as described previously [10].
Briefly, 3 to 5 μm sections were prepared from snap-
frozen synovial tissue, hematoxylin and eosion stained
(Merck, Darmstadt, Germany) and evaluated prior to im-
munohistochemical staining of parallel sections of a suit-
able biopsy including a lining layer with a monoclonal
mouse anti-CD68 antibody (Dako, Glostrup, Denmark).
Hematoxylin and eosion -stained sections were used for de-
termination of the synovitis score according to Krenn and
colleagues [14], which is a semiquantitative four-point sum
scale considering lining layer hypertrophy, inflammatory in-
filtrate, and density of resident cells. For scoring of sublin-
ing CD68 staining, images were photographed at 100×
magnification (Axioskop 2 plus; Carl Zeiss, Jena, Germany;and Nikon DS Vi 1; Nikon, Düsseldorf, Germany) and
stored in TIF format (resolution of 1,600 × 1,200). ImageJ
software [15] was used to select the sublining layer, and the
image was thresholded to highlight the stained areas but
not the respective isotype controls. The stained area was
calculated as a fraction of the selected region.
Magnetic resonance imaging
MRI was performed on a 3 T MRI system (Magnetom Trio;
Siemens Healthcare, Erlangen, Germany). Perfusion im-
aging (dynamic contrast-enhanced MRI) was acquired
with a dynamic two-dimensional T1-weighted turbo-flash
sequence. Twenty seconds after the beginning of the
sequence, the contrast agent Magnevist® (Gd-DTPA, Bayer
Healthcare, Leverkusen, Germany) was injected at a dosage
of 0.4 ml/kg body weight. The acquisition parameters of the
dynamic contrast-enhanced MRI sequence were: repetition
time = 333 milliseconds, echo time = 1.46 milliseconds,
acquisition time per scan acquisition time = 1.7 seconds,
flip angle = 8°, field of view = 120 × 120 mm, 200 dynamical
images and five acquired slices with a slice thickness of 4mm.
Perfusion analysis in MCP joint synovial tissue was
assessed using semiquantitative analysis parameters cal-
culated with T-One weighted Perfusion imaging Param-
eter CAlculation Toolkit software (TOPPCAT, Daniel P.
Barboriak, Duke University School of Medicine, Durham,
North Carolina, USA). In definite region of interest
TOPPCAT analyses, the mean signal intensity (S(t)) over
time was employed to calculate the maximum level of syn-
ovial enhancement (ME), the maximum rate of enhance-
ment (MV) per second, and the rate of early enhancement
(REE) 17 seconds after onset of synovial enhancement
using the formulas:
ME ¼ maximum S tð Þð Þ − minimum S tð Þð Þ
MV ¼ maximum S iþ 1ð Þ − S i – 1ð Þð Þ = t iþ 1ð Þ − t i – 1ð Þð Þ
REE ¼ S2 –Sið Þ= Si  17 secondsð Þ  100%
where Si is the signal intensity at time point ti, S1 is the
signal intensity at onset of synovial enhancement, and
S2 is the signal intensity 17 seconds after onset of syn-
ovial enhancement. In our study, REE was calculated
17 seconds after onset of synovial enhancement because
we acquired a dynamic image every 1.7 seconds. Thus,
we used the first 10 breakpoints for REE calculation. In
all patients, the region of interest was defined as the
anatomical area corresponding to the synovial mem-
brane based on contrast-enhanced T1 images.
Statistical analysis
Correlations between MRI parameters (ME, REE, MV)
and parameters of histological synovitis (Synovitis Score,
sublining CD68 staining) or clinical data were calculated
Table 1 Correlation between dynamic MRI and histological signs of synovitis in MCP2 joints according to Spearman
ME REE MV
Synovitis Scorea 0.743 (P = 0.02) 0.228 (P = 0.56) 0.270 (P = 0.48)
Lining layer hypertrophy 0.789 (P = 0.01) 0.177 (P = 0.65) 0.346 (P = 0.36)
Inflammatory infiltrate 0.249 (P = 0.52) 0.053 (P = 0.89) −0.107 (P = 0.78)
Cellular density 0.842 (P = 0.004) 0.408 (P = 0.28) 0.461 (P = 0.21)
Sublining CD68 0.750 (P = 0.02) 0.450 (P = 0.22) 0.567 (P = 0.11)
Significant results in bold. MCP, metacarpophalangeal; ME, maximum synovial enhancement; MRI, magnetic resonance imaging; MV maximum enhancement
velocity; REE, rate of early enhancement. aSynovitis Score according to Krenn and colleagues [14].
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SPSS 22 (IBM, Armonk, NY, USA) was used for analyses.
Results
Nine patients (seven female, two male, age 57.5 ±
14.3 years) were recruited, all of whom adhered to the
study protocol. Mean DAS28 at inclusion was 5.4 (range
3.5 to 7.4). In the follow-up, there were no severe
adverse events within 6 months such as any permanent
tissue damage, damage to nerves or vessels, infections,
thrombosis, or embolisms following arthroscopy of the
MCP2 joint. The median histologic Synovitis Score was
6 (range 1 to 9), corresponding to a high-grade synovitis
(score >4 [14]) in seven of nine patients.
Next, we compared dynamic MRI findings with cli-
nical characteristics of the patients. Patient-rated pain of
the MCP2 joint on a 10-point scale correlated very
strongly with ME (r = 0.848, P <0.005), and to a some-
what lesser extent with REE (r = 0.681, P = 0.04) and
MV (r = 0.695, P = 0.04). No correlations were notedFigure 1 Contrast-enhanced T1-weighted magnetic resonance imagin
synovial enhancement of MCP 2. Illustration of contrast-enhanced T1-weigh
3 (CE-MRI T1), fusion image of CE-MRI T1 and maximum synovial enhancement
imaging (DCE-MRI), and histological samples from the imaged joint stained with
macrophages (CD68). Patient with (A) a high degree of synovitis and (B) a lowbetween the MRI parameters of the MCP2 and the glo-
bal patient assessment on a 10-point scale, total tender
or swollen joint count. Furthermore, a nonsignificant
correlation between the DAS28 and ME (r = 0.661,
P = 0.053) was noted.
Finally, dynamic MRI parameters were compared with
histological signs of synovitis by correlation analysis. As
can be seen in Table 1 and is exemplified in Figure 1,
strong correlations between ME and several histological
measures of synovitis were present. No such correlations
were found for either REE or MV.
Discussion
Recent developments in MRI technology are increasingly
used to visualize all anatomical components of joints in
RA down to a molecular level and permit functional im-
aging; for example, the assessment of synovial perfusion
[16,17]. Findings such as bone marrow edema have
prognostic value for future erosive disease [18]. Many
of these findings have been validated on histologicalg of metacarpophalangeal (MCP) joints 2 and 3 and maximum
ted magnetic resonance imaging of metacarpophalangeal joint 2 and joint
of MCP 2 measured by dynamic contrast-enhanced magnetic resonance
hematoxylin and eosion (HE) or immunohistochemical staining for
degree of synovitis. Red corresponds to a high maximum enhancement.
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[19,20], or synovial contrast enhancement and synovitis
[6,7,9]. These studies have been performed in animal
models or knee joints. However, RA has a predilection
for small joints such as the MCP joints. Owing to a lack
of other data, the validity of MRI findings of synovitis
was hitherto extrapolated from large to small joints
based on the abovementioned pioneering works. In the
present study, we demonstrate that synovitis of MCP
joints measured by ME on dynamic MRI strongly corre-
lates to histological inflammation within the same joint.
Besides conventional histological criteria, this finding ex-
tends to sublining CD68 staining, which is considered
one of the best histological markers for disease activity
in RA by many experts [21]. These data underscore the
validity of dynamic contrast-enhanced MRI for the as-
sessment of the degree of synovitis in small joints.
There are some limitations to this study. The small
sample size is due to the invasiveness of the arthroscopic
procedure and the resultant effort to keep the number
of patients as small as possible with respect to the aim
of the study. In spite of this, significant and consistent
results were obtained. Moreover, additional synovial pa-
rameters could have been assessed such as markers of
diverse cell populations and adhesion molecules. However,
biopsies of MCP joints did not yield material in sufficient
quality for multiple analyses in all cases. Of note, we ap-
plied a comparatively high dose of the contrast agent
Magnevist® according to a standardized RA study protocol
in our facility, which theoretically permits additional ana-
lyses such as delayed gadolinium-enhanced MRI [17].
Conclusion
ME measured by dynamic MRI reflects histologic syno-
vitis and may replace invasive sampling of synovial tissue
in larger studies for the assessment of the degree of
synovitis of small joints such as MCP. Our findings
strongly support the use of dynamic MRI to assess syno-
vitis in small joints of RA patients in a clinical setting.
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